Element Biosciences has secured $175 million in a Series E funding round, led by Samsung Electronics, to accelerate the commercialization of its genomic and multiomic solutions. This follow-on round will fuel global expansion and advance its product roadmap for research, translational science, and diagnostic applications. The company aims to leverage this capital to further develop its innovative technologies.